Bse

NEW DELHI: Bayer CropScience on Tuesday said that its board of directors has approved a proposal to buyback 10,20,408 equity shares of Rs 10 each from all the shareholders of the company on a proportionate basis. At Monday’s close of Rs 4,859.05, the issue amounts to nearly Rs 500 crore. Promoters of the company, who held 68.58 per cent stake in the agro chemical company as of March 31, intend to participate in the buyback offer, the company told stock exchanges. The company said that the offer will be made through the tender offer route using the stock exchange mechanism and that the buyback size does not include any expenses incurred or to be incurred for the buyback like filling fees, advisory fees, public announcement expenses, printing and dispatch expenses, and other incidental and related expenses. “The buyback would be subject to approval of the shareholders by way of a 'special resolution' through postal ballot and all other applicable statutory … [Read more...] about Bayer CropScience approves Rs 500 crore buyback proposal

New Delhi: Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of the API manufacturing facility and has issued a Form 483, with five observations. As per the USFDA, a Form 483 is issued to a firm's management at the conclusion of an inspection when investigator has observed any conditions that in its judgement may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. "The US Food and Drug Administration (FDA) conducted a Pre-Approval Inspection (PAI) and GMP inspection of the Active Pharmaceutical Ingredients (API) manufacturing facility of Biocon Ltd," Biotechnology major said in a filing to BSE. At the conclusion of the inspection of the Bengaluru facility, which took place between January 20-24, 2020, the agency issued a Form 483, with five observations, the filing said. "We will respond to the FDA with a Corrective and Preventive Action Plan (CAPA) and are … [Read more...] about USFDA issues Form 483 with 5 observations to Biocon’s Bengaluru facility

NEW DELHI: Bayer CropScience today posted a 1.47 per cent decline in its net profit at Rs 106.9 crore for the quarter ended June 30, due to rise in expenses. The company had clocked a net profit of Rs 108.5 crore in the same period of 2014-15. Income from operations during the quarter under review rose to Rs 1,398.7 crore from Rs 1,200.7 crore in the same period of the previous fiscal, as per the company's BSE filing. In April this year the company opened a multi-crop breeding station at Karnal in Haryana. Bayer CropScience operates in three business segments- crop protection, bio-science and environmental science -- offering range of products and service backup for modern, sustainable agriculture as well as for non-agricultural applications. … [Read more...] about Bayer CropScience Q1 net marginally down at Rs 107 crore